Audehm, Ralph V3

A/Prof Ralph Audehm

General Practitioner; Carlton Family Medical, Melbourne; Clinical Associate Professor, University of Melbourne, Department of General Practice
A/Prof Ralph Audehm is a GP of 35 years experience. An Honorary Clinical Associate Professor, University of Melbourne, Department of General practice. He has a broad interest in chronic disease management, diabetes, heart disease and transitional research. He has owned his own practice, worked for NGOs as well as in the community health sector. He believes that primary care and general practice is the key to providing better health outcomes for all Australians.

More from this expert

The questions answered in this podcast are listed below. They were compiled by GPs and health professionals around Australia.

Podcasts iconPodcasts

A/Prof Ralph Audehm discusses some of the cholesterol challenges commonly seen in clinical practice.

Podcasts iconPodcasts

Our expert panel, facilitated by A/Prof Ralph Audehm and panelists A/Prof Samantha Hocking and Prof John Dixon, discusses pharmacotherapy for weight management, including options available, GLP-1s and setting realistic weight goals.

Podcasts iconPodcasts

A case-based approach with the latest developments on the incretin (GLP-1, GIP/GLP-1) front.

Videos iconVideos

Expert A/Prof Ralph Audehm answers questions submitted by Australian GPs and healthcare professionals on the topic of Semaglutide.

Podcasts iconPodcasts

In today's podcast, Prof Andrew Sindone and A/Prof Ralph Audehm discuss NT-proBNP’s role in diagnosis, prognosis, and heart failure management, as well as its use in chronic kidney disease.

Podcasts iconPodcasts

In this Product Explainer, A/Prof Ralph Audehm, GP with a special interest in the management of chronic conditions, explains the role of support programs in drug persistence and adherence.

Videos iconVideos

Learn about the latest evidence on incretin-based therapies and how they are changing the landscape of OSA care.

Podcasts iconPodcasts

Hear about why urine ACR is critical, the hidden risks of CKD Stage 3A, and how new therapies like SGLT2 inhibitors and GLP-1 receptor agonists are changing care - even beyond diabetes.

Podcasts iconPodcasts

A practical, case-based panel i showing how kidney, cardiovascular and metabolic risks intersect in diabetes, and how current therapies can be combined for meaningful long term benefit.

Podcasts iconPodcasts

Save 50% on all seminars. Hurry, sale ends Dec 31!

You're invited to attend the Women's & Children's Health Update 2026, Australia's most popular seminar for GPs and healthcare professionals. Secure your seat by midnight Dec 31 and save!